参考文献/References:
1 Krausz Y, Bonne O, Marciano R, et al. Brain SPECT imaging of neuropsychiatric disorders. Eur J Radiol, 1996, 21(3):183-187.
2 Bonne O, Louzoun Y, Aharon I, et al. Cerebral blood flow in depressed patients:a methodological comparison of statistical parametric mapping and region of interest analyses. Psyehiatry Res, 2003, 122(1):49-57.
3 Mayberg HS, Liotti M, Brannan SK, et al. Reciprocal limbic-corticol function and negative mood:converging PET findings in depression and normal sadness. Am J Psychiatry, 1999, 156(5):675-682.
4 Drevets WC. Neuroimaging studies of mood disorder. Biol Psychiatry, 2000.48(8):813-829.
5 Smith D J, Cavanagh JT. Tile use of single photon emission computed tomography in depressive disorders. Nucl Med Commun, 2005, 26(3):197-203.
6 Videbeeh P. PET measurements of brain glucose metabolism and hlood flow in major depressive disorder:a critical review. Acta Psychiat Scand, 2000, 101(1):11-20.
7 Vangu MD, Esser JD, Boyd IH, et al. Effects of electroconvulsive therapy on regional cerebral blood flow measured by 99mtechnetium HMPAO SPECT. Prog Neuropsy chopharmacol Biol Psychiatry, 2003, 27(1):15-19.
8 Tutus A, Simsek A, Sofuoglu S,et al. Changes in regional cerebral blood flow demonstrated by single photon emission computed tomography in depressive disorders:comparison of unipolar vs. bipolar subtypes. Psychiatry. Res, 1998, 83(3):169-177.
9 Davies J, Lloyd KR, Jones IK, et al. Changes in regional cerebral blood flow with venlafaxine in the treatment of major depression. Am J Psychiatry, 2003, 160(2):374-376.
10 Perieo CA. Skaf CR, Yamada A, et al. Relationship between regional cerebral blood flow and separate symptom clusters of major depression:a single photon emission computed tomography study using statistical parametric mapping. Neurosci Lett, 2005, 384(3):265-270.
11 Benabarre A, Vieta E, Martin F, et al. Clinical value of 99mTc-HMPAO SPECT in depressed bipolar Ⅰ patients. Psychiatry Res, 2004, 132(3):285-289.
12 Kruger S, Alda M, Young UF, et al. Risk and resilience markers in bipolar disorder:brain responses to emotional challenge in bipolar patients and their healthy siblings. Am J Psychiatry, 2006, 163(2):257-264.
13 Fountoulakis KN, Iacovides A, Gerasimou G, et al. The relationship of regional cerebral hlood flow with subtypes of major depression. Prog Neuropsychopharmacol Biol Psychiatry, 2004, 28(3):537-546.
14 Gonul AS, Kula M, Bilgin AG, et al. The regional cerebral blood flow changes in major depressive disorder with and without psychotic features. Prog Neuro-psychopharmacol Biol Psychiatry, 2004, 28(6):1015-1021.
15 Bonne O, Krausz Y, Gorfine M, et al. Cerebral hypopeffusion in medication resistant, depressed patients assessed by Tc-99m HMPAO SPECT. J Affect Disord. 1996, 41(3):163-171.
16 Kimura M, Shimoda K, Mizumura S, et al. Regional cerebral blood flow in vascular depression assessed by 123I-IMP SPECT. J Nippon Med Sch, 2003, 70(4):321-326.
17 Drevets WC, Bogers W, Raichle ME, Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of legional glucose metabolism. Eur Neuro psychopharmacol, 2002, 12(6):527-544.
18 Malison RT, Price Lld, Berman R, el al. Reduced brain serotonin transporter availability in major depression as measured by[123I]-2[beta]-carbomethoxy-3[beta]-(4-iodophenyl) tropane and single photon emission computed tomography. Biol Psychiatry, 1995, 44(11):1090-1098.
19 Willeit M. Praschak-Rieder N, Neumeister A, et al.[123I]-[beta]-CIT SPECT imaging shows rednced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol Psychiatry, 2000, 47(6):482-489.
20 van Dyck CH, Malinson RT, Staley JK, et al. Central serotonin transporter availability measured with[123I] [beta]-CIT SPECT in relation to serotonin transporter genotype. Am J Psychiatry, 2004, 161(3):523-531.
21 Cowen PJ. Serotouin receptor subtypes:implications for psychopharmacology. Br J Psychiatry Suppl, 1991, (12):7-14.
22 Klimke A, Larisch R, Janz A, et al. Dopamine D2 receptor binding before and after treatment of major depression measured by[123I] IBZM SPECT. PsychiatlT Res, 1999, 90(2):91-101.
相似文献/References:
[1]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[2]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[3]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[4]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[5]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[6]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[7]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[8]张巧娜,刘汉东.上颌窦上皮-肌上皮癌的CT表现一例[J].国际放射医学核医学杂志,2016,40(3):237.[doi:10.3760/cma.j.issn.1673-4114.2016.03.015]
[9]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[10]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[11]于璟,唐一源.SPECT在抑郁症研究中的应用[J].国际放射医学核医学杂志,2007,31(1):13.
YU Jing,TANG Yi-yuan.The use of SPECT in the study of depression[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(5):13.